Hvilken er prisen på Roche Holding AG (RO)

Prisen på Roche Holding AG (RO) er $483.81

Hva er markedsverdien på Roche Holding AG (RO)

Markedsverdien på Roche Holding AG (RO) er $379.28B

Roche Holding AG (RO) P/B-forhold

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

År	P/B-forhold	Endre
Ikke nok data for de angitte datoene.

År

P/B-forhold

Endre

Ikke nok data for de angitte datoene.

Selskap	P/B-forhold	Forskjell i P/B-forhold	Land
Eli Lilly and Company LLY.US	29.9692	294.86%	US
Johnson & Johnson JNJ.US	7.6479	0.77%	US
AbbVie Inc. ABBV.US	-78.0908	-1,128.89%	US
Merck & Co., Inc. MRK.US	8.5385	12.50%	US
Novartis AG NOVN.SW	6.754	-11.01%	CH

Selskap

P/B-forhold

Forskjell i P/B-forhold

Land